These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16497495)

  • 1. Effect of drug loading on the transformation of vesicular into cubic nanoparticles during heat treatment of aqueous monoolein/poloxamer dispersions.
    Wörle G; Siekmann B; Bunjes H
    Eur J Pharm Biopharm; 2006 Jun; 63(2):128-33. PubMed ID: 16497495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of vesicular into cubic nanoparticles by autoclaving of aqueous monoolein/poloxamer dispersions.
    Wörle G; Siekmann B; Koch MH; Bunjes H
    Eur J Pharm Sci; 2006 Jan; 27(1):44-53. PubMed ID: 16157479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of composition and preparation parameters on the properties of aqueous monoolein dispersions.
    Wörle G; Drechsler M; Koch MH; Siekmann B; Westesen K; Bunjes H
    Int J Pharm; 2007 Feb; 329(1-2):150-7. PubMed ID: 16987623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug release from differently structured monoolein/poloxamer nanodispersions studied with differential pulse polarography and ultrafiltration at low pressure.
    Rosenblatt KM; Douroumis D; Bunjes H
    J Pharm Sci; 2007 Jun; 96(6):1564-75. PubMed ID: 17094136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases.
    Siekmann B; Bunjes H; Koch MH; Westesen K
    Int J Pharm; 2002 Sep; 244(1-2):33-43. PubMed ID: 12204563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control over Particle Size Distribution by Autoclaving Poloxamer-Stabilized Trimyristin Nanodispersions.
    Göke K; Roese E; Arnold A; Kuntsche J; Bunjes H
    Mol Pharm; 2016 Sep; 13(9):3187-95. PubMed ID: 27463039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of lamellar-to-cubic and intercubic phase transitions of pure and cytochrome c containing monoolein dispersions monitored by time-resolved small-angle X-ray diffraction.
    Kraineva J; Narayanan RA; Kondrashkina E; Thiyagarajan P; Winter R
    Langmuir; 2005 Apr; 21(8):3559-71. PubMed ID: 15807602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin containing monoolein aqueous dispersions: a preformulative study.
    Esposito E; Ravani L; Mariani P; Contado C; Drechsler M; Puglia C; Cortesi R
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4923-34. PubMed ID: 24094206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolipid based cubic nanoparticles: preparation and structural aspects.
    Abraham T; Hato M; Hirai M
    Colloids Surf B Biointerfaces; 2004 May; 35(2):107-17. PubMed ID: 15261043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispersed lipid liquid crystalline phases stabilized by a hydrophobically modified cellulose.
    Almgren M; Borné J; Feitosa E; Khan A; Lindman B
    Langmuir; 2007 Feb; 23(5):2768-77. PubMed ID: 17309220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin.
    Lai J; Chen J; Lu Y; Sun J; Hu F; Yin Z; Wu W
    AAPS PharmSciTech; 2009; 10(3):960-6. PubMed ID: 19636709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of dispersed cubic phases with blood components.
    Bode JC; Kuntsche J; Funari SS; Bunjes H
    Int J Pharm; 2013 May; 448(1):87-95. PubMed ID: 23524124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the stabilizer concentration on the internal liquid crystalline order and the size of oil-loaded monolinolein-based dispersions.
    Guillot S; Salentinig S; Chemelli A; Sagalowicz L; Leser ME; Glatter O
    Langmuir; 2010 May; 26(9):6222-9. PubMed ID: 20143786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-containing PEGylated cubosomic particles: freeze-fracture electron microscopy and synchrotron radiation circular dichroism study.
    Angelov B; Angelova A; Papahadjopoulos-Sternberg B; Hoffmann SV; Nicolas V; Lesieur S
    J Phys Chem B; 2012 Jul; 116(26):7676-86. PubMed ID: 22720820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant-containing monoolein aqueous dispersions: a preliminary study.
    Sguizzato M; Drechsler M; Baldisserotto A; Cortesi R; Esposito E
    Drug Deliv Transl Res; 2022 Aug; 12(8):1873-1880. PubMed ID: 35084708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat Treatment of Poloxamer-Stabilized Triglyceride Nanodispersions: Effects and Underlying Mechanism.
    Göke K; Roese E; Bunjes H
    Mol Pharm; 2018 Aug; 15(8):3111-3120. PubMed ID: 29989820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles.
    Kupetz E; Bunjes H
    J Control Release; 2014 Sep; 189():54-64. PubMed ID: 24933601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Useful modified cellulose polymers as new emulsifiers of cubosomes.
    Uyama M; Nakano M; Yamashita J; Handa T
    Langmuir; 2009 Apr; 25(8):4336-8. PubMed ID: 19296640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerized bicontinuous cubic nanoparticles (cubosomes) from a reactive monoacylglycerol.
    Yang D; O'Brien DF; Marder SR
    J Am Chem Soc; 2002 Nov; 124(45):13388-9. PubMed ID: 12418883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles.
    Kuntsche J; Bunjes H
    Eur J Pharm Biopharm; 2007 Nov; 67(3):612-20. PubMed ID: 17574399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.